Skip to Content
Merck
CN

19210

Butyric acid

puriss., ≥99.5% (GC)

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
CH3CH2CH2COOH
CAS Number:
107-92-6
Molecular Weight:
88.11
EC Number:
203-532-3
UNSPSC Code:
12352100
MDL number:
MFCD00002814
Beilstein/REAXYS Number:
906770

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI

1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)

InChI key

FERIUCNNQQJTOY-UHFFFAOYSA-N

SMILES string

CCCC(O)=O

vapor density

3.04 (vs air)

vapor pressure

0.43 mmHg ( 20 °C)

grade

puriss.

assay

≥99.5% (GC)

autoignition temp.

824 °F

expl. lim.

10 %

bp

162 °C (lit.)

mp

−6-−3 °C (lit.)

density

0.964 g/mL at 25 °C (lit.)

Looking for similar products? Visit Product Comparison Guide

pictograms

CorrosionExclamation mark
GHS05,GHS07

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Skin Corr. 1B - STOT SE 3

target_organs

Respiratory system

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 1

flash_point_f

161.6 °F - closed cup

flash_point_c

72 °C - closed cup

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Naofumi Kaneko et al.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 132(7), 849-853 (2012-07-14)
Antimicrobial agents occasionally cause certain adverse effects, such as diarrhea and loose stool, by altering the composition of the intestinal flora. Antibiotic-resistant lactic acid bacteria are used to prevent these adverse effects. Although these bacteria are not resistant to several
J J Mallo et al.
Journal of animal science, 90 Suppl 4, 227-229 (2013-02-13)
Three tests, 2 in vivo and 1 in vitro, were conducted to compare how 2 forms of protection of butyric acid (BA) affect its liberation along the gastrointestinal tract (GIT) of piglets. The 2 forms of BA were vegetable fat-encapsulated
Grethe Skretting et al.
Molecular biology reports, 39(12), 10089-10096 (2012-08-31)
There is now circumstantial evidence that tissue factor pathway inhibitor (TFPI) is not only a major anticoagulant, but also has proapoptotic properties. The current study was designed to address the role of TFPI on signalling pathways and apoptosis. The non-TFPI
Kristel Rochus et al.
The British journal of nutrition, 109(6), 1022-1030 (2012-08-11)
The present study evaluated the potential of affecting amino acid metabolism through intestinal fermentation in domestic cats, using dietary guar gum as a model. Apparent protein digestibility, plasma fermentation metabolites, faecal fermentation end products and fermentation kinetics (exhaled breath hydrogen
Mirosława Gałecka et al.
Polish journal of microbiology, 62(1), 91-95 (2013-07-09)
The aim of the study was evaluation of the correlation between the level of clinical activity of Crohn's disease (CD) and the number of Faecalibacterium prausnitzii, total number of bacteria and the concentration of selected short chain fatty acids (SCFA)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service